MedPath

Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients

Not Applicable
Completed
Conditions
Insulin Resistance
Type 2 Diabetes
Registration Number
NCT01857167
Lead Sponsor
Zhejiang University
Brief Summary

This study is to examine the change of fasting insulin, glucose, insulin sensitivity and related traits in response to the six month treatment of omega-3 fatty acids, including fish oil and flaxseed oil, in Chinese type 2 diabetic patients. Corn oil, rich in omega-6 fatty acids, will be selected as a controlled oil. The investigators hypothesize that omega-3 fatty acids could improve insulin sensitivity and glucose metabolism in Chinese type 2 diabetic patients.

Detailed Description

The insulin resistance will be estimated by a homeostatic model assessment model of insulin resistance (HOMA-IR)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
185
Inclusion Criteria
  1. Fasting glucose > 7.0 or have diabetes medication;
  2. Male, 35-80 years; female, postmenopausal to 80 years;
  3. Agree to participant in the trial.
Exclusion Criteria
  1. Deny to sign the informed consent;
  2. type 1 diabetes;
  3. Family history of hypertriglyceridemia or fasting triglyceride>4.56 mmol/L;
  4. Have severe liver disease, kidney disease or cancer;
  5. Participating in the other clinical trial within 30 days;
  6. Other diseases or conditions, for which the doctor of the patients do not agree his or her participating.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
insulin resistance180 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

Zhejiang University
🇨🇳Hangzhou, Zhejiang, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.